Marshall Wace Asia’s Boston Scientific BSX Stock Holding History

Marshall Wace Asia’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$95.1M	Buy	2,190,737 +920,459	+72%	+$40.7M	2.25%	13
2021 Q2	$54.3M	Sell	1,270,278 -194,842	-13%	-$8.2M	1.15%	32
2021 Q1	$56.6M	Buy	+1,465,120	New	+$55.5M	1.26%	31
2020 Q3	–	Sell	-10,261	Closed	-$360K	–	136
2020 Q2	$360K	Buy	+10,261	New	+$370K	0.01%	102
2020 Q1	–	Sell	-133,362	Closed	-$6.03M	–	132
2019 Q4	$6.03M	Buy	+133,362	New	+$5.58M	0.15%	63
2019 Q1	–	Sell	-2,863,642	Closed	-$101M	–	98
2018 Q4	$101M	Buy	2,863,642 +603,056	+27%	+$21.9M	3.72%	3
2018 Q3	$87M	Buy	+2,260,586	New	+$79M	2.95%	10

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Marshall Wace Asia's BSX Position: Q3 2021 in Review

Marshall Wace Asia increased its Boston Scientific (BSX) stake by 72% in Q3 2021, buying an estimated $40.7M and bringing the position to 2,190,737 shares worth $95.1M. The position accounts for 2.25% of the portfolio, ranked #13.

Marshall Wace Asia first reported a position in BSX in Q3 2018 and has held it in 7 quarters since. The position peaked at $101M in Q4 2018. 879 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

Marshall Wace Asia held 2,190,737 shares of Boston Scientific worth $95.1M as of Q3 2021.
Marshall Wace Asia bought 920,459 Boston Scientific shares in Q3 2021, an estimated $40.7M.
Boston Scientific made up 2.25% of Marshall Wace Asia's portfolio in Q3 2021, its #13 holding.
Marshall Wace Asia first reported a position in Boston Scientific in Q3 2018 and has held it in 7 quarters since.
Marshall Wace Asia's Boston Scientific position peaked at $101M in Q4 2018.
879 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on Marshall Wace Asia's 13F filing for Q3 2021, filed 15 Nov 2021.